The Mount Sinai Health System is deploying blood-based biomarkers and confirmatory tests for Alzheimer's disease and related dementias, enabling early detection and intervention. The system aims to stratify patients rapidly, non-invasively, and cost-effectively.
Researchers identified changes in the UBR4 gene as a key driver of fibromuscular dysplasia, a blood vessel disorder affecting up to five percent of adults. The discovery could lead to therapeutic approaches for the condition, particularly beneficial for women who account for 90% of cases.
Researchers at Mount Sinai developed an AI model that predicts brain blood pressure using noninvasive data, enabling swift detection of critical changes and potentially saving lives. The study showed strong performance in detecting intracranial pressure within seconds.
Researchers found that an aging immune system spurs tumor growth by promoting inflammation, which can drive cancer development. Blocking specific inflammatory pathways may reverse this process, offering a potential new approach to preventing cancer development in humans.
A new five-year grant will explore the mammary gland's influence on metabolic diseases like obesity and type 2 diabetes. The research aims to identify specific hormones produced by the mammary gland, known as mammokines, which may impact obesity and diabetes in mothers and offspring.
Researchers at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles that could revolutionize how cancer and other diseases are diagnosed. These molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer.
A new study found that the incidence of hepatitis C virus (HCV) reinfection among men with HIV is 10-fold higher than primary infection rates in New York City. The researchers identified receiving semen in the rectum as the only risk factor for reinfection, contradicting previous assumptions about transmission routes.
Researchers from Mount Sinai and City of Hope demonstrate a combination treatment that increases human insulin-producing beta cells by 700% in mice with diabetes. This breakthrough could lead to new treatments for the hundreds of millions of people with diabetes worldwide.
A recent study published in Nature Medicine has shown that pulsed field ablation (PFA) is a safe and effective treatment for patients with atrial fibrillation. The study analyzed over 17,600 patients and found no significant risk of esophageal damage or other complications, increasing confidence in the use of PFA technology.
The Mount Sinai researchers have developed a comprehensive epidemiological dataset for youth diabetes and prediabetes research, derived from NHANES data collected from 1999 to 2018. The newly launched POND portal aims to facilitate an understanding of factors that may influence youth diabetes risk.
Researchers found major differences between postmortem and living prefrontal cortex brain tissues, with higher levels of RNA editing in postmortem tissues. These discoveries will shape the development of diagnostics and therapies for brain diseases, highlighting the need to study both living and postmortem samples.
A recent study published in Critical Care Medicine found that real-time machine learning alerts significantly improved patient outcomes by predicting clinical deterioration. The study showed that patients who received AI-generated alerts were 43% more likely to have their care escalated and had a lower risk of death.
Researchers used an advanced AI tool to identify rare coding variants in 17 genes linked to coronary artery disease, shedding light on its molecular basis. The findings could lead to novel risk identification and treatment targets for cardiovascular care.
Researchers will study FSH's role in obesity, osteoporosis, and Alzheimer's disease. The grant aims to develop new treatments for these conditions and improve quality of life for older adults worldwide.
Researchers from Mount Sinai presented three studies on obstructive sleep apnea (OSA) at SLEEP 2024, exploring its effects on thalamic activity, overnight memory performance, and symptom improvement with CPAP treatment. The findings suggest that OSA can impair cognitive function and that hypoxic burden may predict clinical improvement.
Researchers identified a genetic cause of intellectual disability, caused by mutations in the non-coding gene RNU4-2, which affects tens of thousands of people worldwide. The discovery is significant, as it represents one of the most common single-gene genetic causes of neurodevelopmental disorders.
A clinical trial led by Mount Sinai researchers shows zodasiran, an RNA inhibitor targeting ANGPTL3, significantly reduces various types of cholesterol and triglycerides. The therapy also lowers apolipoprotein B, a lipid-transporting protein linked to heart disease.
A groundbreaking study published in Nature Neuroscience provides new insights into brain cell communication and opens the door to innovative treatment strategies for Alzheimer's disease. The research team identified a novel way to potentially slow down or halt disease progression by manipulating the plexin-B1 protein.
Two studies published in Science reveal significant advances in understanding the molecular biology of neuropsychiatric disease, including a comprehensive map of regulatory components of the brain. The research provides critical insights into the pathogenesis of mental health disorders and holds promise for therapeutic applications.
Researchers from Mount Sinai will present new research on long COVID, lung cancer, asthma, and sleep apnea at the ATS 2024 International Conference. The studies aim to improve diagnosis and care for these conditions.
A study published by the Icahn School of Medicine at Mount Sinai found that generative AI models like GPT-4 can accurately predict hospital admissions from limited records. The research suggests that AI could support doctors in emergency rooms with quick, informed decisions about patient admissions.
Researchers designed a regenerative medicine therapy to speed up diabetic wound repair using tiny fat particles loaded with genetic instructions. The treatment targeted problem-causing cells and reduced swelling, promoting faster and more effective wound closure.
Researchers at Mount Sinai identified genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD), highlighting potential for joint therapeutic strategies. The study found mutations in the LRRK2 gene as a common element linking both conditions, with implications for innovative treatments.
Researchers have shed light on the mechanisms by which psychedelic drugs, such as LSD and psilocybin, bind to and activate serotonin receptors. The study highlights the potential therapeutic benefits of these compounds in treating depression and anxiety disorders.
A study by Mount Sinai researchers has identified several pathophysiological mechanisms underlying perianal fistulae in Crohn’s disease. The findings highlight key transcription factor binding events and epigenetic phenomena that contribute to the higher rates of complications in African American patients. The research provides avenues...
Researchers revealed the biological mechanisms by which class II HDACs activate Th17 cell differentiation, leading to inflammation. A potent inhibitor, TMP269, was found to influence Th17 cell differentiation in a mouse model of ulcerative colitis, providing potential therapeutic approach for IBD treatment.
A study published in NEJM AI found that large language models are poor at reproducing original medical codes, highlighting the need for refinement and validation. Despite this, one model showed improved performance and potential applications for automating medical code extraction and billing accuracy.
Researchers identified alterations in the monkeypox virus genome that correlate with increased transmissibility, shedding light on the 2022 outbreak. The study's findings may help develop more effective prevention and treatment strategies.
Researchers have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems. A largely overlapping population of cells respond to both addictive drugs and natural rewards, leading to behavior directed toward drug-seeking and away from natural rewards.
Researchers found that withdrawing aspirin one month after PCI significantly reduced major and minor bleeding incidents by 55% compared to dual antiplatelet therapy. The study, ULTIMATE-DAPT, showed no increase in adverse ischemic events, suggesting continuing aspirin may cause harm without benefit.
A new study found that inter-atrial shunts improve symptoms and outcomes in heart failure patients with reduced left ventricular ejection fraction (LVEF), but worsen outcomes in those with preserved LVEF. The device reduces high pressures in the left atrium, causing shortness of breath and hospitalizations.
A Mount Sinai study found that primary care physicians' approach to selecting patients with comorbidities for lung cancer screening is influenced by subjective clinical judgments. The researchers recommend streamlined protocols and clearer guidelines to increase adoption of lung cancer screening for this high-risk population.
Researchers at Mount Sinai School of Medicine have identified macrophages as crucial in clearing lipid-rich waste from the brain. By studying genes controlling these immune cells, they discovered that two specific genes BHLHE40 and BHLHE41 regulate their activity.
Researchers used machine learning to identify key predictors of mortality in dementia patients across various types. The study found neuropsychological test results were a better predictor of mortality risk than age-related factors, highlighting the potential for personalized care and more effective interventions.
A long-term analysis of over 8,000 samples revealed that SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting. Booster vaccination equalized differences in antibody concentration between participants with and without pre-existing immunity.
A recent study has shed light on the vital role of the immune system in lung cancer risk, particularly among smokers. The research found that individuals with heterozygosity at HLA-II genes experienced a decreased risk of lung cancer.
A new study published in JAMA Ophthalmology suggests that artificial intelligence can match or exceed the expertise of seasoned ophthalmic specialists in diagnosing and treating patients with glaucoma and retina disorders. The AI system, GPT-4, demonstrated superior performance in response to glaucoma questions and case-management advice.
Using intravascular imaging to guide stent implantation significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI. The study found a 25% reduction in all-cause death, 45% reduction in cardiac death, and improved outcomes for patients with coronary artery disease.
A phase 2 study by Mount Sinai-led researchers demonstrates rusfertide's ability to limit excess red blood cell production in patients with polycythemia vera, a rare and chronic blood cancer. The results suggest it could replace therapeutic phlebotomy, providing improved treatment options for patients.
A study of over 1,000 tumors across 10 different cancers reveals complex interplay of immune cells in tumors. The research aims to identify patient groups more responsive to immunotherapy and develop new treatment strategies.
Researchers from Mount Sinai will present studies on preventing and treating fetal growth restriction, including the use of antenatal steroids and machine learning models for predicting surgical morbidity in placenta accreta spectrum. These findings aim to improve neonatal outcomes and maternal care.
A new study from the Icahn School of Medicine of Mount Sinai reveals significant variations in emergency medical service (EMS) performance across the United States. The research found that EMS agencies in rural areas were less likely to provide optimal care, including treating low blood sugar and pain for trauma patients.
Researchers at Mount Sinai Health System developed a novel protocol for rapid diagnosis of eye stroke, improving outcomes and preserving vision. The protocol uses high-resolution retinal imaging in emergency rooms, along with remote consultation, to confirm diagnosis and expedite care.
A global task force of scientists created an integrative framework to study emotions and moods, situating experiences within a single theoretical framework. This framework helps understand mental disorders like depression and anxiety, as well as decision-making and human behavior.
Researchers at Mount Sinai Hospital have discovered that circulating immune cells can be drawn to the brain during stress and alter emotional behavior. The study found that these immune cells release an enzyme called MMP8, which breaks down proteins in the brain and impairs social behavior.
A team of researchers has identified a way to turn on a vital bacterial defense mechanism to fight and manage bacterial infections. By leveraging the cyclic oligonucleotide-based antiphage signaling system (CBASS), bacteria can self-destruct to prevent viral attacks, offering a fresh approach to tackling antibiotic resistance.
The Eric and Wendy Schmidt AI in Human Health Fellowship Program will support five fellows over three years, leveraging AI to advance medical research and foster interdisciplinary collaborations. The program aims to attract exceptional talent and provide a platform for groundbreaking research.
Researchers discovered that cisplatin chemotherapy enhances the immune system's ability to fight bladder cancer by modulating the immune response and damaging DNA in cancer cells. This approach may lead to durable disease control in a subset of patients with metastatic bladder cancer.
The Icahn School of Medicine at Mount Sinai will investigate the pre-disease phase of Crohn's disease, identifying unique biomarkers to predict and prevent its development. The $4 million grant aims to transform healthcare by focusing on early intervention and prevention strategies.
Researchers discovered a previously unreported neuron type with vulnerability in Parkinson's disease, shedding light on the complexity of the disease and potential therapeutic targets. The study identified distinct transcriptomic signatures of this neuron type and found reduced RIT2 expression in Parkinson's disease patients.